“showed a trend”

Potentially unnecessary utilization of blood transfusion did not vary by surgeon (range: 1% to 4%; p=0.142), but was higher in TRAM flap reconstructions (OR: 9; p=0.001) and showed a trend for higher ASA class (OR: 3; p=0.076).

1 ) ( p < 0.001 for both), and showed a trend for greater respiratory resistance ( p = 0.076).

Another finding contrary to our hypothesis was the observation that macrophage content showed a trend ( P = 0.076) toward a reduction by approximately one‐third in muscles of treated compared with control mice (Fig. 5 ).

The impaired patients showed a trend toward significance for more errors than zero in the no distracter condition, t (5) = 2.23, p = 0.076, with three out of six patients making at least one error.

Results Patients with abnormal levels of S100β showed a trend towards higher delirium duration ( P =0.076); Group B (standard deviation) (7.0 [3.2] days), Group C (5.5 [6.3] days), and Group D (5.3 [6.0] days), compared to patients in Group A (3.5 [5.4] days).

Surgical time exceeding 4 h showed a trend toward higher risk (OR = 1.87, 95% CI: 0.94–3.75, P = 0.076), while anesthesia time greater than 4 h was significantly associated with elevated risk (OR = 2.97, 95% CI: 1.44–6.12, P = 0.003).

In Vp4 PVTT patients, pre-PSM analysis showed a trend toward improved survival in the HTP group (13.3 vs. 11.4 months; HR=0.64; 95% CI: 0.39-1.05; P =0.076), which became statistically significant post-PSM (15.3 vs. 9.3 months; HR=0.51; 95% CI: 0.26-0.98; P =0.040).

Obese patients demonstrated significantly reduced range of motion in both active forward flexion ( p = 0.035) and external rotation ( p = 0.024), and showed a trend toward higher postoperative pain ( p = 0.076) and poorer functional recovery compared to non-obese patients.

In fact, the discharge FIM-mobility subscore showed a trend favoring the COX-2 group ( P = 0.076).

Somewhat surprisingly, at 9 months, the Q175 Het and Hom mutants showed a trend towards better performance on the test than the WT controls ( F 2,22 = 2.935, P = 0.076), but this paradoxical finding was reversed by 12 months, where there was a gene dose-dependent decline in motor function ( Fig. 6A ; F 2,22 = 11.557, P <0.001) with post hoc comparisons revealing that Het mice performed worse than WT ( t = 2.419, P = 0.025) and Hom mice performed worse than both age-matched Het and WT mice ( vs Het t = 2.225, P = 0.0378; vs WT t = 4.806, P = 0.017).

Age ≥6 years at onset showed a trend toward TR (HR 2.99, 95% CI 0.89–10.02, p = 0.076, figure 3C ).

However, after adjusting for age, initial NIHSS correlated positively with the FLT‐binding ratio ( r = 0.61, p = 0.035) and early NIHSS decline showed a trend toward positive correlation with the FLT‐binding ratio ( p = 0.076); after additional adjustment for infarct volume, the significance was lost, but there was still a trend toward positive correlation between early NIHSS decline and FLT‐binding ratio ( p = 0.147).

Notably, within this subgroup, patients receiving ≥ 2 cycles of neoadjuvant immunochemotherapy showed a trend towards better overall survival ( P = 0.076) and disease-free survival ( P = 0.062).

When compared with BC alone, this dual modality for tissue examination showed a trend toward increasing sensitivity from 36.1% to 50.7% ( p = 0.076).

Bivariate correlations between N2 amplitude at T4 and the change in N2 amplitude between T2 and T4 with self-perceived improvement in everyday auditory communication, assessed via SSQ-B1–3 did not achieve statistical significance but showed a trend for a moderate negative correlation between N2 amplitude at T4 and the improvement of speech comprehension (SSQ-B1: r = −0.471, p = 0.076) and localization (SSQ-B2: r = −0.494, p = 0.061) recorded at the T4 assessment.

Highly positive RIPK3 expression was significantly associated with lower OS (HR 1.697, 95% CI 1.058–2.721, log-rank p = 0.027) and showed a trend toward lower DFS (HR 1.501, 95% CI 0.955–2.361, log-rank p = 0.076) ( Table 2 and Figure 3 ).

Participants’ responses showed a trend of being slower when switching entailed greater costs ( t 28 = 1.844, p = 0.076, CI 95 = [−0.003 to 0.056], U3 1 = 0.345).

We also observed that Oga +/- mice showed a trend toward reduced hanging time compared to wild-type controls (p=0.076) suggesting impaired muscular performance.

Scaled B‐cell abundance scores declined in about two‐thirds of cases, while NK‐cells showed a trend towards an increase ( P = 0.076; Figure S2E,F ).

EG_hi trauma patients showed a trend towards slower recovery (Kaplan-Meier analysis: log-rank p value = 0.076, Hazard Ratio [HR] = 0.74 [95%CI: 0.53–1.03], Figure 4 c), compared with EG_lo patients.

Although Group B showed a trend toward fewer missed or false-positive lesions, this did not reach statistical significance (p = 0.076).

Although the E4/DRSP group showed a trend toward a shorter duration from pill initiation to ovulation than the EE/GS group (4.71 ± 1.60 days vs. 6.86 ± 2.27 days), the difference was not significant ( p = 0.076).

Additionally, a trend toward better PFS was observed in patients with p53 positivity ≥50% (HR: 0.66 [95% CI: 0.40–1.08], p = 0.097), whereas patients harboring L858R showed a trend toward poor outcome (HR: 1.68 [95% CI: 0.95–2.97], p = 0.076).

The duration of illness only showed a trend of correlation with baseline PANSS total scores ( R 2 = 0.02, p = 0.076).

Maintenance therapy showed a trend toward improved outcomes (2-year OS 91.7% vs 54.7%, P = 0.076).Elevated D-dimer (≥1945 μg/L) correlated with worse survival (median OS 16.4 months vs NR, P = 0.002).